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-Amino acid ester hydrolases (AEHs) catalyze the hy-
drolysis and synthesis of esters and amides with an
-amino group. As such, they can synthesize -lactam
antibiotics from acyl compounds and -lactam nuclei
obtained from the hydrolysis of natural antibiotics. This
article describes the gene sequence and the 1.9-Å reso-
lution crystal structure of the AEH from Xanthomonas
citri. The enzyme consists of an /-hydrolase fold do-
main, a helical cap domain, and a jellyroll -domain.
Structural homology was observed to the Rhodococcus
cocaine esterase, indicating that both enzymes belong to
the same class of bacterial hydrolases. Docking of a
-lactam antibiotic in the active site explains the sub-
strate specificity, specifically the necessity of an
-amino group on the substrate, and explains the low
specificity toward the -lactam nucleus.
-Lactam antibiotics form a large family of widely applied
antibacterials. Most of them are derived from a handful of
naturally occurring antibiotics like penicillin G, penicillin V,
and cephalosporin C by replacing their acyl groups with
synthetic ones. Initially, this was achieved by chemical
means but at present, enzymatic methods are preferred (1). A
well known enzyme used for these conversions is penicillin
acylase (EC 3.5.1.11) from Escherichia coli. This enzyme is
used both for the production of the -lactam nucleus 6-amin-
openicillanic acid (6-APA)1 by cleaving off phenylacetic acid
from penicillin G and for the coupling of new acyl groups to
6-APA or other -lactam nuclei. Penicillin acylase is, however
strongly inhibited by its product phenylacetic acid (2), which
must therefore be removed before coupling of a new acyl
group to the -lactam nucleus can take place. In addition,
-lactam nuclei are not very stable at the alkaline pH opti-
mum of penicillin acylase.
By contrast, -amino acid ester hydrolases (AEHs) do not
have these disadvantages. These enzymes catalyze the hydrol-
ysis and synthesis of esters and amides of -amino acids exclu-
sively, and do not attack the amide bond of a -lactam. They
can be used to acylate a -lactam using an ester as acyl donor,
as shown in Fig. 1. Because the AEHs require an -amino
group on the substrate, they are not inhibited by phenylacetic
acid (3). Together with their ability to accept various -lactam
nuclei without cleaving them, this makes them suitable for
generating widely used antibiotics such as ampicillin, amoxi-
cillin, and the cephalosporins cephadroxil and cephalexin. The
slightly acidic pH optimum of AEH, which is beneficial for
-lactam stability, is another advantage of AEHs for biocata-
lytic applications, as is their stereospecificity toward the acyl
donor (4).
One of the first AEHs that was isolated and characterized is
the enzyme from Xanthomonas citri (5–11). This enzyme was
found to be a homotetramer with subunits of 72 kDa (6). Ki-
netic studies indicated the occurrence of an acyl-enzyme inter-
mediate in the hydrolysis and acylation reactions of -lactam
antibiotics (3, 7, 12).
This article reports the gene and 1.9-Å resolution crystal
structure of the AEH from X. citri. The structure is the first in
this family of -lactam antibiotic acylases. The catalytic do-
main consists of the well known /-hydrolase fold, with a
classical catalytic triad. The X. citri AEH structure highlights
a peculiar active site, in which a classical Ser-His-Asp catalytic
triad is combined with unusual features like a rare oxyanion
hole composed of a main chain amide and a tyrosine side chain,
and a cluster of negatively charged residues, which is likely
involved in substrate recognition. Genetic comparisons show
the conservation of these features that allows the structural
definition of a novel family of serine hydrolases.
EXPERIMENTAL PROCEDURES
Materials—Antibiotics and related compounds were provided by
DSM Life Sciences (Delft, The Netherlands). Oligonucleotides for clon-
ing of the AEH-encoding gene were provided by Eurosequence (Gron-
ingen, The Netherlands). Chemicals used in DNA manipulation proce-
dures were purchased from Roche Diagnostics GmbH (Mannheim,
Germany) and used as recommended by the manufacturer. DNA se-
quences were determined at the Department of Medical Biology of the
University of Groningen.
Bacterial Strains, Plasmids, and Growth Conditions—X. citri IFO
3835 was grown for 16 h at 28 °C in a 10-liter fermentor on the medium
described by Takahashi et al. (5) with the addition of 0.005% (w/v)
FeSO4. E. coli strains HB101 (13) and the methionine-deficient strain
E. coli B834(DE3) (Novagen Inc., Madison, WI) were used for cloning
derivatives of pEC (DSM Life Sciences). E. coli XL1 Blue MR (Strat-
agene, La Jolla, CA) was the host for a genomic library of X. citri in the
cosmid pWE15 (AmpR) (Stratagene). For production of the selenome-
thionine-incorporated protein, E. coli B834(DE3) carrying the construct
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pXc (see below) was grown for 30 h at 30 °C on M9 medium (14)
supplemented with a vitamin and spore solution (15), DL-selenomethi-
onine (100 mg/liters), chloramphenicol (34 mg/liters), and isopropyl--
D-thiogalactopyranoside (0.4 mM).
Isolation of -Amino Acid Ester Hydrolase from X. citri and Amino
Acid Sequence Determination—The -amino acid ester hydrolase from
X. citri was purified essentially as described for the Acetobacter turbi-
dans AEH (16). For sequence analysis of X. citri AEH, 100 g of
protein was sliced from a SDS-PAGE gel and digested with trypsin.
From the digest, those peptides containing a tryptophan (high absorb-
ance at 297 nm) were selected for sequencing. Eurosequence BV (Gron-
ingen, The Netherlands) carried out further preparation of the sample
and determined the amino acid sequence by automated Edman degra-
dation (model 477A, Applied Biosystems).
Preparation and Screening of the X. citri Genomic Library—The gene
encoding the AEH from X. citri (aehX) was cloned from a genomic DNA
cosmid library via Southern blotting. To this end, genomic DNA from X.
citri was isolated and partially digested with Sau3A as described before
(16). The conditions were optimized to obtain fragments of 30–45 kb.
These were ligated in cosmid pWE15 (Ampr), which had been digested
with BamHI and dephosphorylated with alkaline phosphatase. In vitro
packaging and infection of E. coli XL1 Blue MR was carried out accord-
ing to the recommendations of the manufacturer of the DNA packaging
kit (Roche Diagnostics). Part of the gene encoding X. citri AEH was
cloned by PCR amplification from chromosomal DNA using two primers
based on the determined internal amino acid sequences, pF, 5-AAYC-
CNAGYGARGTNGAYCAYGC-3, and pR, 5-YTTRTGCCACCANG-
GNARYTGYTC-3 (Y is T or C; R is A or G; N is any base). The PCR
product was isolated from gel (QiaQuick kit, Qiagen, GmbH, Hilden,
Germany), cloned, and sequenced. A gene probe for the aehX gene was
made using matching primers based on the DNA sequence of the PCR
fragment. The forward primer was 5-ACCGATGCCTGGGACACC-
3(upstream of pF) and the reverse primer was 5-CAGGCCTGCGGC-
CTTGGC-3 (downstream of pR). These primers were used to amplify a
317-bp fragment with Taq polymerase using the PCR DIG probe syn-
thesis mixture from Roche Diagnostics. To obtain the whole gene,
colony hybridization with the cosmid library was carried out as de-
scribed by Polderman-Tijmes et al. (16) using the specific probe.
Cloning of aehX into an Expression Host—For expression of aehX in
E. coli, it was placed under control of a tac promotor in the pEC vector
(17), resulting in pXc. For cloning in the NdeI/HindIII site of pEC the
gene was amplified with the primers, 5-TCCGGAGTCATTAATGCGC-
CGCCTTGCCAC-3 (AsnI site underlined, start codon in bold) and a
reverse primer, 5-ACCGGTGCCAAGCTTTCAACGTTACCGGCAG-3
(HindIII site underlined, stop codon in bold). After denaturation of the
DNA (pWE15 (aehX)) amplification was performed in 30 cycles of 30 s
at 94 °C, 1 min at 58 °C, and 1 min and 30 s at 72 °C. Product and vector
were both subjected to restriction, and subsequently ligated. The liga-
tion mixture was used to transform E. coli HB101.
Enzyme Assays and Determination of Kinetic Constants—AEH activ-
ities were routinely measured by incubating purified X. citri AEH with
a substrate at varying concentrations in 50 mM phosphate buffer, pH
7.0, at room temperature. The hydrolysis products were analyzed by
high performance liquid chromatography (18). Cephalexin hydrolysis
was measured in a concentration range from 0.95 to 15 mM; ampicillin
from 0.5 to 15 mM; phenylglycine methylester from 4 to 250 mM; 4-hy-
droxyphenylglycine methylester from 0 to 30 mM; amoxicillin from 0.5
to 15 mM; cefatrizine from 0.3 to 15 mM. Cephadroxil, phenylacetic acid
methylester, and penicillin G were all used at 10 mM, but phenylglycine
at 40 mM.
Two potential inhibitors were tested by following their effect on the
hydrolysis of 50 mM phenylglycine methylester in 50 mM sodium phos-
phate, pH 6.2. A 0.1 M stock solution of 2,4-dinitrobenzenesulfenyl
chloride was made in 50 mM sodium phosphate, pH 7.0. Phenylmeth-
ylsulfonyl fluoride was dissolved at 0.1 M in methanol. 2,4-Dinitroben-
zenesulfenyl chloride was used at 1 mM with 400 nM enzyme (70-kDa
monomer), whereas the effect of phenylmethylsulfonyl fluoride was
evaluated at 4 mM with 10–20 nM enzyme (final concentrations). The
effects of the solvents were measured separately and used to correct the
inhibitory effects.
Isolation of Recombinant Selenomethionine-incorporated X. citri
-Amino Acid Ester Hydrolase from E. coli—Selenomethionine-AEH
was purified from E. coli B834(DE3) (pXc) cells grown in the presence of
100 mg/liter DL-selenomethionine. The selenomethionine-incorporated
enzyme was purified as described above with the addition of 5 mM
dithiothreitol to all buffers to prevent oxidation of the selenium. The
enzyme was concentrated to 5 mg/ml in 20 mM cacodylate buffer, pH
6.5, by ultrafiltration (YM30, Amicon).
Crystallization—Protein crystals were grown essentially as de-
scribed earlier (19). Briefly, 1.5 l of concentrated X. citri AEH was
mixed with an equal volume of 12–15% PEG 8000 in 0.1 M cacodylate,
pH 6.5, and equilibrated against 500 l of this precipitant solution.
Prior to freezing, crystals were briefly soaked in 15% PEG 8000 in 0.1
M MES, pH 6.5, to remove the arsenic-containing cacodylate, as arsenic
has spectral properties comparable with those of selenium that inter-
fere with MAD data collection around the selenium wavelength. Crys-
tals were cryoprotected by soaking for a few seconds in 25% glycerol,
15% PEG 8000 in 0.1 M MES, pH 6.5.
Data Collection and Structure Determination—A three-wavelength
MAD dataset was collected to 2.5-Å resolution from a crystal of sel-
enomethionine-labeled protein at the BW7A beamline of the EMBL
outstation at the DESY synchrotron in Hamburg, Germany. Also, 80%
complete native data to 1.8 Å were collected at the ID14-2 beamline of
the ESRF in Grenoble, France. Additionally, a 1.9-Å resolution dataset
was collected at the BW7B beamline at DESY, Hamburg. All data were
processed with the HKL package (20). Using the peak wavelength data
of the MAD dataset, 62 selenium sites could be identified using the
program Shake-and-Bake (21) with standard settings (22). These sites
were refined against the full three-wavelength MAD dataset using the
program SOLVE (23), which was also used for the calculation of phases.
Solvent flattening was performed with RESOLVE (24), resulting in an
electron density map of excellent quality. The resolution was extended
to 1.8 Å using ARP/wARP (25) and the incomplete data from ID14-2,
after which the autotracing option in wARP (26) built 98% of the
structure. No averaging was applied at any stage.
Refinement and Model Building—Refinement was performed using
the program REFMAC5 (27) against the 1.9-Å data from BW7B, with-
out using a  cutoff. No NCS was imposed at any stage. The current
model contains 2452 amino acids, 1806 water molecules, four calcium
ions, and nine glycerol molecules. Rebuilding was done with XtalView
(28). Docking of ampicillin in the active site was done with Quanta
(Accelrys) and CNS (29).
RESULTS AND DISCUSSION
The AEH Family of -Lactam Antibiotic Acylases—The gene
for the -amino acid ester hydrolase from X. citri encodes a
polypeptide of 637 amino acids with a calculated molecular
weight of 70,915. A BLAST search (30) with the deduced amino
acid sequence revealed an identical sequence, annotated as a
glutaryl 7-ACA acylase, from Xanthomonas axonopodis pv. citri
strain 306 (protein ID number AAM37193) (31). Other proteins
with high sequence identities (93, 78, 62, and 61%, respec-
tively) are the putative glutaryl 7-ACA acylases from Xan-
thomonas campestris pv. campestris strain ATCC 33913 (pro-
tein ID number AAM41516 (31), Xylella fastidiosa (protein ID
number AAF83839), and Zymomonas mobilis (protein ID num-
ber AAD29644), and the -amino acid ester hydrolase from A.
turbidans (protein ID number AF439262 (16)). Lower sequence
identities (28%) were found with the glutaryl 7-ACA acylase
FIG. 1. Transacylation reaction catalyzed by -amino acid ester hydrolases, resulting in antibiotic formation. As an example, the
synthesis of ampicillin from D-phenylglycine methylester and 6-APA is shown. The AEHs can also hydrolyze antibiotics, cleaving them at the amide
bond to the side chain, not at the lactam bond.
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from Bacillus laterosporus (protein ID number BAA10148
(32)) and cocaine esterase cocE from Rhodococcus sp. (protein
ID number AAF42807 (33)) of which the structure has been
published (34). A sequence alignment of the proteins from X.
citri, X. fastidiosa, Z. mobilis, A. turbidans, B. laterosporus,
and Rhodococcus sp. is shown in Fig. 2. No sequence similar-
ity to any known -lactam antibiotic acylase other than the
B. laterosporus glutaryl 7-ACA acylase was found, supporting
the hypothesis that the AEHs constitute a new family of
-lactam antibiotic acylases, which contains the proteins
from the Xanthomonas strains, A. turbidans, X. fastidiosa,
and Z. mobilis.
FIG. 2. Sequence alignment of members of the proposed family of AEHs from X. citri (Xc) and A. turbidans (At), X. fastidiosa (Xf),
and Z. mobilis (Zm), the 7-ACA glutaryl acylase from B. laterosporus (Bl), and the cocaine esterase from Rhodococcus sp. (Rs). A green
box indicates the catalytic triad residues, a blue box those forming the oxyanion hole, and a red box the residues involved in binding the -amino
moiety. Residues binding the calcium are surrounded by a purple box, and the cysteines forming the disulfide bridge by a yellow box. The gray box
shows the putative N-terminal leader peptide.
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Quaternary Structure—X. citri AEH was overproduced in
selenomethionine-labeled form and crystallized as described
before (19). Phases were obtained using multiwavelength
anomalous dispersion, and the model was built almost entirely
through automated methods. The structure was refined to crys-
tallographic and free R-factors of 14.9 and 17.8%, respectively,
at a resolution of 1.9 Å. Data and model statistics are shown in
Table I.
The asymmetric unit was found to contain a tetramer, which
is approximately spherical, with a diameter of 100 Å (Fig.
3A). A tetrameric arrangement is in agreement with gel
filtration and ultracentrifugation studies of the X. citri AEH
by Kato et al. (6). The four monomers form an approximate
tetrahedron and enclose a large water-filled space with two
large entrances. All four active sites (see below) are on the
inside of the tetramer, facing the water-filled space and are
accessible only through these entrances. The four monomers
are virtually identical, their C atoms superimposing to
within 0.2 Å.
The N terminus of each molecule is observed from Thr-24
onwards. From Thr-24, the polypeptide forms a 40-Å long
“arm” (residues 24–44) that lies on the surface of an adjacent
monomer. This monomer, in turn, places its N-terminal arm
onto the first monomer. Thus, the tetramer is composed of two
dimers of which each monomer donates its N terminus to the
other molecule of the same dimer. The large entrances to the
central cavity lie between these two arms. The interaction of
the two monomers in the dimer buries a surface of 3700 Å2,
almost all of which is because of interactions involving the
arms. The interacting surfaces of a monomer with the mono-
mers of the other dimer within the tetramer measure 2,100
and 1,100 Å2. In total, 14,000 Å2 are buried by inter-mono-
mer contacts within the 280-kDa tetramer. Several of these
contacts are formed by hydrogen bonds, involving both main
chain and side chain atoms.
Monomer Structure—The monomer (Fig. 3B) consists of an
N-terminal /-hydrolase fold (35) with large insertions, and a
C-terminal domain that consists largely of -strands with a
jellyroll topology, with extra elements of secondary structure in
the crossover loops.
The /-hydrolase fold domain consists of a central, mostly
parallel -sheet of 10 -strands, flanked on either side by
-helices (Fig. 4A). The second strand runs antiparallel to the
others. Like in other /-hydrolases (35), the twist in the cen-
tral sheet is large, with a difference in orientation of the first
and the last strand of about 90 degrees. At the end of the fifth
strand, a very tight turn into a helix contains Ser-174, which is
thus observed in the common position for the nucleophile in
/-hydrolase fold enzymes. As usual in /-hydrolases (36),
this residue adopts an unfavorable main chain conformation
(  64.9°,   119.3°, averaged over all four monomers). A
loop protruding from strand 3 (residues 82 to 101) covers
strands 1, 2, and 4 of the central -sheet and approaches
the connection between the N-terminal arm and strand 1 (Fig.
4A). The polypeptide chain continues into helix A (residues
105–109) that contacts strand 4. The predominantly helical
cap domain (residues 199–278, Fig. 4B) connects strand 6 and
helix D as is usual in /-hydrolase enzymes. From strand 6,
a loop (residues 199–209) extends into a small two-stranded
antiparallel -sheet (strand 9, residues 210 and 211 and
strand 10, residues 214–215) followed by helices G (220–
227), H (243–250), I (253–259), and J (266–273). The chain
continues into helix D (residues 279–291), which flanks the
central sheet. Between strand 8 and helix F, a -hairpin
turn (strands 11 and 12, residues 349–350 and 353–354,
respectively) is formed. After helix F, an additional two
TABLE I
Data collection and refinement statistics
Rsym  hkl iIhkl,i  Ii/hkl i Ihkl,i for the intensity I of i observations of reflection h. R-factor  Fobs  Fcalc/ Fobs (Fobs  observed structure
factor, Fcalc  calculated structure factor). Rfree  R-factor calculated with 5% of randomly chosen data that were omitted from the refinement.
Values in parentheses are for the highest resolution shell.
Data collection
Dataset
Selenomethionine MAD on BW7A
ID14–2 BW7B
Peak Inflection Remote
Wavelength (Å) 0.9779 0.9783 0.9392 0.933 0.846
Space group P21 P21 P21
Unit cell
a 89.80 89.98 89.77
b 125.86 125.78 126.02
c(Å) 132.14 132.08 132.29
(°) 91.0 90.9 90.94
Resolution (Å) 2.35 2.35 2.25 1.80 1.90
Observations 1,873,199 1,872,141 1,067,980 1,742,445 1,307,283
Unique reflections 99721 97017 99732 205579 220969
Completeness (%) 99.7 (96.9) 99.7 (96.8) 99.6 (95.8) 81.4 (45.3) 95.6 (95.8)
Rsym 0.074 (0.183) 0.057 (0.178) 0.061 (0.195) 0.077 (0.378) 0.055 (0.210)
Refinement







R-factor highest resolution shell (1.900-1.949 Å) 0.211
Rfree 0.178
Rfree highest resolution shell (1.900-1.949 Å) 0.242




Most favored regions (%) 87.4%
Allowed (%) 12.3%
Disallowed (%) 0.3%
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strands are seen at the end of the central -sheet, strand 13
(parallel, residues 388–392), and strand 14 (antiparallel, res-
idues 397–401).
The C-terminal domain adopts a jellyroll fold, which is con-
nected to the /-hydrolase domain via a small linker, which is
tightened into a compact structure by a disulfide bond between
Cys-408 and Cys-412. The hydrogen bonding pattern is broken
at the edges of the two antiparallel -sheets of the jellyroll
(strands 17, 18, 22, 25, 29, and 20, 23, 24, and 27) such that
a -sandwich rather than a -barrel is formed. In the crossover
loops, two small antiparallel two-stranded -sheets are formed
(strands 19/28 and 21/26), closing the -sandwich of the
jellyroll on either side to create a box-like structure. Two inser-
tions project away from this box. The first insertion (residues
446–481) contains an -helix, which comes into close proximity
of the active site and may thus play a role in catalysis. The other
FIG. 3. A, stereo representation of the
X. citri AEH tetramer, looking through
the large entrance into the central cavity.
Each monomer is individually colored.
The figure was prepared using Molscript
(45). B, stereo representation of the X.
citri AEH monomer. The /-hydrolase
fold domain is colored green, the cap do-
main orange, and the C-terminal jellyroll
domain blue. The catalytic Ser-174 is
shown in ball-and-stick representation.
The figure was prepared using Molscript
(45).
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insertion (residues 525 to 535) makes contacts with two other
monomers and contributes to tetramer formation.
The fold of the monomer resembles that of the cocaine ester-
ase from Rhodococcus sp. (cocE) of which the structure was
previously published (34). The structures can be superimposed
to a root mean square difference of 2.3 Å for 390 corresponding
C atoms. Whereas the /-hydrolase and jellyroll domains are
similar, differences are observed in the cap domain and the
insertions in the jellyroll domain. The cap domain of cocE is
larger, extending into the region where the entrance to the
tetramer is found in X. citri AEH. Arranging four cocE mole-
cules in a way similar to the AEH tetramer shows that the
entrances to the central cavity would be severely blocked by the
larger cap domains of cocE. More recently, the structure of
the Lactococcus lactis X-prolyl dipeptidyl aminopeptidase PepX
was published, which exhibits the same three-domain fold and
organization as AEH and cocE, apart from an additional N-
terminal domain involved in oligomerization (37), like the N-
terminal arms in AEH.
A Novel Calcium Binding Site Structurally Distinct from the
EF-hand—On the surface of the tetramer and opposite the
active site, a metal ion is bound by the side chains of Glu-322,
Asp-325, Asn-328 (through its O-), and the main chain car-
bonyl oxygen of Asn-331. It is further coordinated by two water
molecules, one of which is hydrogen bonded to the hydroxyl
group of Tyr-318. This results in a pentagonal-bipyramidal
coordination sphere consisting of only oxygen atoms. The ion
was modeled as a calcium ion. Refinement of the structure with
a magnesium ion in this position was unsatisfactory because it
yielded unrealistically low B-factors for the ion. All coordinat-
ing amino acids stem from the same loop (Fig. 5), which con-
nects helix E with strand 8. This is in contrast to the situa-
tion in EF-hands, where the calcium binding loop is found
between two helices. In X. citri AEH, the coordinating residues
(X) form an XXXX motif (Fig. 2) in which every third residue
coordinates the ion, again in contrast to the EF-hand case
(XXXXXX) (38). This binding motif is therefore distinctly
different from the EF-hand and represents a novel calcium ion
binding motif. Sequence alignment of the proteins from X. citri,
A. turbidans, X. fastidiosa, B. laterosporus, and Z. mobilis
shows this motif to be present only in the X. citri and X.
fastidiosa sequences. The calcium binding motif is also not
observed in cocE.
Active Site Structure—The catalytic Ser-174 is found on the
“nucleophilic elbow” between strand 5 and helix C. Its posi-
tion in this narrow turn places it near the N-terminal end of the
10-residue long helix C, which can stabilize negative charges
through its helix dipole (35). Ser-174 is roughly in the middle
of a distinct active site pocket. It is in close contact with
His-340, which in turn is hydrogen bonded to Asp-307. These
FIG. 5. Stereo figure of the calcium binding motif. The coordi-
nating residues are indicated. The figure was prepared using Bobscript
(46) and Raster3D (47).
FIG. 4. Topology diagrams of the different domains in X. citri AEH. A, /-hydrolase fold domain (residues 24–205 and 286–404). B, the
mainly -helical cap domain (residues 206–284). C, the jellyroll domain (residues 405–637) with two large insertions and several smaller
insertions. The disulfide bond between Cys-408 and Cys-412 is indicated.
Structure of -Amino Acid Ester Hydrolase 23081
residues constitute a catalytic triad (Fig. 6, A and B) and are
found in the canonical positions in the sequence (36): Ser-174
on the turn between strand 5 and helix C, His-340 on the
linker between strand 8 and helix F, and Asp-307 between
strand 7 and helix E. The orientation of the His-340 N- is
unfavorable for hydrogen bond formation with the Ser-174
O-, but a 10° rotation around the His-340 	1 could remedy
this.
In many catalytic triads of serine hydrolases, a hydrogen
bond-like interaction is observed between the His C-
 and a
backbone carbonyl group. This interaction has been proposed
by Derewenda et al. (39) to stabilize the positively charged
imidazolinium intermediate developing during catalysis. How-
ever, in the case of AEH, the distance between the His-340 C-

and the nearest backbone carbonyl (of Ser-198) is too large (3.9
Å) for this interaction to have much effect. On the other hand,
the His-340 C-
 is just 3 Å away from the Asp-310 O-, which
might perform the proposed stabilizing function. However, the
imidazole ring and the Asp-310 carboxylate moiety are far from
coplanar. We therefore believe that this interaction is a not a
hydrogen bond as such, but that it can stabilize the imidazo-
linium ion through Coulomb interactions.
In /-hydrolases, the backbone amide of the residue directly
following the catalytic nucleophile stabilizes the ionic interme-
diate by forming part of an oxyanion hole. In the case of X. citri
AEH, a water molecule is observed close to the backbone NH of
Tyr-175 (Fig. 6B), in the position expected for the oxyanion. An
additional contribution to the stabilization of the oxyanion
could be made by the side chain hydroxyl group of Tyr-82,
which forms a hydrogen bond with the water molecule.
The architecture of the oxyanion hole (Fig. 6B) is identical to
that observed in cocE and PepX. Apart from these enzymes, the
only other enzyme known to use a tyrosine side chain in oxya-
nion stabilization is prolyl oligopeptidase. Is has been noted
(40–42) that because of the lower pKa of tyrosine side chains,
they could be more capable of oxyanion stabilization than the
backbone or side chain amides used for this purpose in other
enzymes. Furthermore, enzymes in which a side chain contrib-
utes to the oxyanion hole are ideal enzymological model sys-
tems because the oxyanion hole can be easily modified by
site-directed mutagenesis (41–43).
Next to the catalytic histidine, a cluster of carboxylate
groups protrudes into the active site (Fig. 6A). This cluster is
formed by Asp-208, Glu-309, and Asp-310. Glu-309 and Asp-
310 are in the loop that connects strand 7 and helix E,
whereas Asp-208 is part of the loop between strand 6 and the
cap domain. A survey of homologous genes shows that these
residues are absolutely conserved among the proteins from the
proposed family of AEHs (Fig. 2), but are not present in the B.
laterosporus glutaryl acylase or the Rhodococcus sp. cocaine
esterase. Consequently, this cluster of acidic residues may be
crucial to the -amino acid ester hydrolase function. A charac-
teristic of this function is the importance of the -amino group
of the substrate, which is obvious from Table II. Substrates
without an -amino group, such as penicillin G and phenylac-
etic acid methylester are not hydrolyzed by X. citri AEH. Also,
the broadly active serine hydrolase inhibitor phenylmethylsul-
fonyl fluoride, which does not contain an amino group, did not
appreciably inhibit X. citri AEH (90% residual activity). Fur-
thermore, it has been shown that the enzyme has a preference
for the positively charged form of the amino-containing sub-
strates (3). Given the position of Asp-208, Glu-309, and Asp-
310, close to the catalytic Ser-174 residue, it is conceivable that
these residues are responsible for the recognition of the
-amino group of the substrate and would thus constitute a
structural feature of major importance for the function of the
enzyme.
The proximity of the side chains of Asp-208, Glu-309, and
Asp-310 in the active site would lead to an energetically unfa-
vorable clustering of negatively charged atoms requiring sta-
bilization. One way in which the enzyme stabilizes the cluster-
ing of negative charge is through a hydrogen bond of the O-
 of
Glu-309 with the N-
 of Trp-465, which is conserved in the
AEHs of the Xanthomonas strains, X. fastidiosa, A. turbidans,
and Z. mobilis. Trp-465 is part of the helical insertion in the
jellyroll domain (residues 448–481), which is located close to
the carboxylate cluster. The importance of a tryptophan resi-
due for activity is corroborated by the reduction in activity of
the enzyme (65% residual activity) in the presence of 2,4-
dinitrobenzenesulfenyl chloride, which reacts with tryptophan
residues.
Together with the high sequence homology, the conservation
of the residues forming the carboxylate cluster in the putative
acylases from X. fastidiosa and Z. mobilis identifies these pro-
teins as AEHs, in contrast with their previous annotations as
7-ACA glutaryl acylases. On the other hand, the absence of
these residues in the B. laterosporus sequence makes it un-
likely that the latter protein is an AEH.
Modeling of Substrate in the Active Site—To visualize how
the cluster of Asp-208, Glu-309, and Asp-310 could recognize
the -amino group of the substrate, we have manually docked
an ampicillin molecule into the active site based on the posi-
tions of the catalytic serine, the oxyanion hole, and the nega-
tively charged cluster (Fig. 6C). The amide bond of ampicillin
was placed close to the nucleophilic Ser-174, with the amide
oxygen in the oxyanion hole, making hydrogen bonds to the
backbone amide of Tyr-175 and the phenolic OH of Tyr-82.
FIG. 6. The active site of AEH. A, stereo representation of the
active site of X. citri AEH. The residues involved in binding and catal-
ysis are shown. The main chain trace is colored according to the domain
architecture (green, /-hydrolase domain; orange, cap domain). The
A-weighted 2Fo  Fc electron density map is contoured at 1.2 . B,
close-up of the residues of the catalytic triad, and those forming the
oxyanion hole. The water molecule occupying the oxyanion hole is also
shown. C, stereo figure of the model of ampicillin binding to X. citri
AEH. The figure was prepared using Bobscript (46) and Rasterd3D (47).
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The -amino group could then be positioned to make electro-
static interactions with the cluster of carboxylates formed by
Asp-208, Glu-309, and Asp-310. To remove unfavorable con-
tacts, a short energy minimization was carried out in which
only the ampicillin molecule was allowed to move. In the
resulting model, aromatic ring stacking interactions occur
between the aromatic ring of phenylglycine and Tyr-222.
Furthermore, the model predicts a stacking interaction be-
tween the phenylglycine ring and the side chain of Asp-208.
The side chains of Met-200, Trp-209, and Asp-219 further
delimit the pocket binding the phenyl ring. These residues
belong to the cap domain, which shows a large degree of
structural and functional variation within the /-hydrolase
family (36). In the structurally related cocaine esterase, the
cap domain binds the acyl group of the ester, which is con-
sistent with our model. Because AEHs differ in their selec-
tivity toward various antibiotics with substituted phenyl
rings, differences in sequence would be expected in the re-
gions just described.
The model predicts few interactions with the -lactam
nucleus, although stacking interactions with Tyr-82 seem
likely. In addition to this, some polar residues extend into the
space where the -lactam is located. The relative paucity of
interactions with the -lactam nucleus is consistent with the
fact that both penicillin- and cephalosporin-derived nuclei
can bind.
Conclusions and Implications—We present here the first
structure of an -amino acid ester hydrolase. The X. citri
AEH structure shows a peculiar spherical tetrameric state,
which would only allow enzymatic action toward small
molecules.
The X. citri AEH monomer displays a three-domain fold
consisting of an /-hydrolase fold domain, a cap domain, and
a C-terminal domain with a jellyroll fold. Within the active site,
a canonical Ser-His-Asp catalytic triad is observed, but an
interesting cluster of acidic residues close to the catalytic his-
tidine sets the enzyme apart from other serine esterases. Given
the remarkable specificity for substrates with a charged am-
monium group, it is likely that this “carboxylate cluster” is
responsible for recognition and binding of this group, as illus-
trated by molecular modeling. The conservation of this cluster,
furthermore, allows the definition of an AEH family at the
genetic level, distinguishing the AEHs from structurally re-
lated esterases and peptidases.
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